- Home
- NBY vs QLYS Comparison
NBY vs QLYS Comparison
Compare NBY & QLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- QLYS
- Stock Information
- Founded
- NBY 2000
- QLYS 1999
- Country
- NBY United States
- QLYS United States
- Employees
- NBY N/A
- QLYS N/A
- Industry
- NBY
- QLYS Computer Software: Prepackaged Software
- Sector
- NBY
- QLYS Technology
- Exchange
- NBY Nasdaq
- QLYS Nasdaq
- Market Cap
- NBY 15.7M
- QLYS 4.7B
- IPO Year
- NBY 2007
- QLYS 2012
- Fundamental
- Price
- NBY $2.60
- QLYS $133.46
- Analyst Decision
- NBY Strong Buy
- QLYS Hold
- Analyst Count
- NBY 1
- QLYS 15
- Target Price
- NBY $0.85
- QLYS $141.00
- AVG Volume (30 Days)
- NBY 21.3M
- QLYS 290.1K
- Earning Date
- NBY 11-06-2025
- QLYS 11-04-2025
- Dividend Yield
- NBY N/A
- QLYS N/A
- EPS Growth
- NBY N/A
- QLYS 10.84
- EPS
- NBY 0.41
- QLYS 5.02
- Revenue
- NBY $9,781,000.00
- QLYS $637,019,000.00
- Revenue This Year
- NBY $23.91
- QLYS $10.58
- Revenue Next Year
- NBY $32.05
- QLYS $6.44
- P/E Ratio
- NBY $6.50
- QLYS $26.58
- Revenue Growth
- NBY 113.47
- QLYS 9.63
- 52 Week Low
- NBY $0.46
- QLYS $112.61
- 52 Week High
- NBY $4.44
- QLYS $170.00
- Technical
- Relative Strength Index (RSI)
- NBY 58.86
- QLYS 49.12
- Support Level
- NBY $2.28
- QLYS $131.22
- Resistance Level
- NBY $3.12
- QLYS $137.00
- Average True Range (ATR)
- NBY 0.57
- QLYS 2.97
- MACD
- NBY 0.04
- QLYS 0.16
- Stochastic Oscillator
- NBY 48.32
- QLYS 37.02
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About QLYS Qualys Inc.
Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.